ExoVectory

ExoVectory

Private
LeidenHealthcare & Life Scienceshttps://exovectory.com/

Last Round

Grant

Apr 8, 2024

Total Funding Raised

$1.04M

Momentum Score

25 /100

Company Overview

ExoVectory is a biotechnology company that develops exosomes as a revolutionary new type of delivery system for gene therapeutics.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

exosome therapeuticsgene therapy deliverynon-viral gene deliverydrug delivery platformexosome loading technologycell and gene therapyCGTnon-viral vectorCRISPR deliveryAAV alternativelarge payload deliveryex vivo T-cell engineeringoncology therapeuticsbiotech out-licensingglioblastoma treatment

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ExoVectory Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

ExoVectory Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
GrantApr 8, 2024
GrantApr 6, 2023
GrantNov 23, 2021
Pre SeedNov 24, 2020

ExoVectory Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 6, 2026

    Monthly visitors grew 220% MoM.

  • Apr 8, 2024

    Received funding from Eureka Network and Eurostars SME programme.

ExoVectory Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

ExoVectory Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about ExoVectory's valuation, stock price, and market status.

Firmographic Details

HeadquartersLeiden
Employee Range5
Year Founded2020
Last FundingApr 8, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.